RetractedArticleImmunity, inflammation and disease2024

Oxaliplatin activates P53/miR-34a/survivin axis in inhibiting the progression of gastric cancer cells.

Qiang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.